Page last updated: 2024-09-04

febuxostat and Acute Symptom Flare

febuxostat has been researched along with Acute Symptom Flare in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (36.36)24.3611
2020's7 (63.64)2.80

Authors

AuthorsStudies
Afinogenova, Y; Danve, A; Neogi, T1
Lee, J; Min, J; Saag, KG; Shin, S; Terkeltaub, R1
Cheng, X; Li, C; Li, H; Lu, J; Sun, R; Xin, Y1
Choi, HK; Solomon, DH; Yoshida, K1
Cui, X; Geng, H; Jia, E; Jiang, Y; Li, B; Ma, W; Qiu, X; Wei, J; Xiao, M; Xiao, Y; Xie, J; Yao, X; Zhang, J; Zhang, Y; Zhong, L1
Tausche, AK1
Ahn, SM; Hong, S; Kim, YG; Lee, CK; Oh, JS; Yoo, B1
Neogi, T; Vargas-Santos, AB1
Fujimori, S; Hidaka, Y; Ide, Y; Inoue, K; Kim, H; Sugimoto, M; Tamaki, S; Taniguchi, A; Yamamoto, T; Yamanaka, H1
Singh, JA1
Hildebrand, BA; Jaster, P; Westgate, J1

Reviews

2 review(s) available for febuxostat and Acute Symptom Flare

ArticleYear
Update on gout management: what is old and what is new.
    Current opinion in rheumatology, 2022, 03-01, Volume: 34, Issue:2

    Topics: Allopurinol; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Symptom Flare Up

2022
Medications for gout and its comorbidities: mutual benefits?
    Current opinion in rheumatology, 2021, 03-01, Volume: 33, Issue:2

    Topics: Allopurinol; Comorbidity; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Observational Studies as Topic; Symptom Flare Up

2021

Trials

4 trial(s) available for febuxostat and Acute Symptom Flare

ArticleYear
Serum Urate-Lowering Efficacy and Safety of Tigulixostat in Gout Patients With Hyperuricemia: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Trial.
    Arthritis & rheumatology (Hoboken, N.J.), 2023, Volume: 75, Issue:7

    Topics: Double-Blind Method; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Symptom Flare Up; Treatment Outcome; Uric Acid

2023
Evaluation of febuxostat initiation during an acute gout attack: A prospective, randomized clinical trial.
    Joint bone spine, 2020, Volume: 87, Issue:5

    Topics: Febuxostat; Gout; Gout Suppressants; Humans; Neoplasm Recurrence, Local; Prospective Studies; Symptom Flare Up; Treatment Outcome

2020
Initiation of febuxostat for acute gout flare does not prolong the current episode: a randomized clinical trial.
    Rheumatology (Oxford, England), 2021, 09-01, Volume: 60, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Single-Blind Method; Symptom Flare Up; Treatment Outcome; Uric Acid

2021
Stepwise dose increase of febuxostat is comparable with colchicine prophylaxis for the prevention of gout flares during the initial phase of urate-lowering therapy: results from FORTUNE-1, a prospective, multicentre randomised study.
    Annals of the rheumatic diseases, 2018, Volume: 77, Issue:2

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colchicine; Dose-Response Relationship, Drug; Febuxostat; Gout; Gout Suppressants; Humans; Incidence; Male; Middle Aged; Prospective Studies; Symptom Flare Up; Uric Acid

2018

Other Studies

5 other study(ies) available for febuxostat and Acute Symptom Flare

ArticleYear
[Gout].
    Der Internist, 2021, Volume: 62, Issue:5

    Topics: Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Symptom Flare Up; Uric Acid

2021
Comparative efficacy of low-dose versus regular-dose colchicine to prevent flares in gout patients initiated on urate-lowering therapies.
    Rheumatology (Oxford, England), 2021, 12-24, Volume: 61, Issue:1

    Topics: Adult; Aged; Allopurinol; Cohort Studies; Colchicine; Drug Therapy, Combination; Febuxostat; Female; Gout; Gout Suppressants; Humans; Male; Middle Aged; Retrospective Studies; Symptom Flare Up

2021
Management of Gout and Hyperuricemia in CKD.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 70, Issue:3

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Diet Therapy; Disease Management; Febuxostat; Gout; Gout Suppressants; Humans; Hyperuricemia; Male; Middle Aged; Renal Dialysis; Renal Insufficiency, Chronic; Symptom Flare Up; Treatment Outcome; Uric Acid

2017
Goals of gout treatment: a patient perspective.
    Clinical rheumatology, 2018, Volume: 37, Issue:9

    Topics: Allopurinol; Febuxostat; Female; Goals; Gout; Gout Suppressants; Humans; Life Style; Male; Middle Aged; Patient Education as Topic; Symptom Flare Up

2018
Digital Tophaceous Gout.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2016, Volume: 22, Issue:6

    Topics: Allopurinol; Drug Costs; Febuxostat; Fingers; Gout; Gout Suppressants; Health Equity; Humans; Male; Middle Aged; Symptom Flare Up

2016